MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Axonics Modulation Technologies DPO Ratio 2011-2026 | AXNX
Annual DPO Ratio Axonics Modulation Technologies
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.1 | 51.8 | 67.9 | 331 | 3.52 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.52 K | 40.1 | 803 |
Quarterly DPO Ratio Axonics Modulation Technologies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.8 | 63 | 70.5 | - | - | - | - | - | 23.8 | 25.2 | 54.2 | - | 57.9 | 55.6 | 72.2 | - | 72.4 | 115 | 76.3 | - | 849 | 695 | 776 | - | 2.96 K | 62.7 K | - | - | 625 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 62.7 K | 23.8 | 3.85 K |
DPO Ratio of other stocks in the Medical devices industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
61.8 | $ 2.21 | -0.43 % | $ 3.45 M |  USA |
 |
Alphatec Holdings
ATEC
|
73.8 | $ 12.93 | -0.92 % | $ 1.94 B | USA |
 |
Acutus Medical
AFIB
|
92.7 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
23.1 | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
43.9 | $ 10.53 | 0.77 % | $ 1.42 B | USA |
 |
ClearPoint Neuro
CLPT
|
33.2 | $ 9.69 | -13.17 % | $ 274 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
81.3 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
10.5 | - | 24.59 % | $ 44.8 M |  China |
 |
Cytosorbents Corporation
CTSO
|
125 | $ 0.66 | -2.96 % | $ 35.9 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
224 | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.6 | $ 3.82 | -5.91 % | $ 142 M |  France |
 |
Avinger
AVGR
|
45.5 | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
81.1 | $ 8.32 | -0.48 % | $ 597 M |  Israel |
 |
Establishment Labs Holdings
ESTA
|
248 | $ 65.54 | 0.81 % | $ 1.94 B |  Costa-rica |
 |
Aziyo Biologics
AZYO
|
286 | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
51.3 | $ 4.06 | -4.92 % | $ 859 M | USA |
 |
BIOLASE
BIOL
|
66.7 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
50.4 | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
61.7 | $ 70.78 | -0.59 % | $ 105 B | USA |
 |
Apollo Endosurgery
APEN
|
63.6 | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
57.3 | $ 37.4 | 0.16 % | $ 1.16 B | USA |
 |
CryoLife, Inc.
CRY
|
41.1 | - | -4.14 % | $ 702 M | USA |
 |
Cutera
CUTR
|
57.2 | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
72.7 | $ 13.57 | -0.62 % | $ 877 M | Israel |
 |
CHF Solutions, Inc.
CHFS
|
204 | - | 1.15 % | $ 34.5 M | USA |
 |
IRIDEX Corporation
IRIX
|
50.7 | $ 1.33 | - | $ 21.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
52.2 | - | 14.99 % | $ 929 K | USA |
 |
Itamar Medical Ltd.
ITMR
|
131 | - | 0.03 % | $ 1.58 B | Israel |
 |
OrthoPediatrics Corp.
KIDS
|
79.4 | $ 16.8 | -2.38 % | $ 394 M | USA |
 |
Misonix, Inc.
MSON
|
83.1 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
48.6 | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
16.6 | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
Intersect ENT, Inc.
XENT
|
72.8 | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
79.7 | $ 109.06 | -1.49 % | $ 190 B | USA |
 |
Delcath Systems
DCTH
|
56 | $ 9.49 | -2.57 % | $ 340 M | USA |
 |
Bio-Rad Laboratories
BIO
|
41 | $ 269.13 | -0.13 % | $ 7.59 B | USA |
 |
Helius Medical Technologies
HSDT
|
362 | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
AxoGen
AXGN
|
34.4 | $ 31.04 | -5.22 % | $ 1.43 B | USA |
 |
Align Technology
ALGN
|
33.7 | $ 172.05 | -2.31 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
43.8 | $ 8.93 | -1.92 % | $ 688 M | USA |
 |
Bruker Corporation
BRKR
|
46.4 | $ 34.17 | 1.27 % | $ 5.09 K | USA |
 |
Apyx Medical Corporation
APYX
|
52.3 | $ 3.74 | -0.13 % | $ 154 M | USA |
 |
Second Sight Medical Products
EYES
|
21 | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
49.2 | $ 0.39 | -0.46 % | $ 40.1 M | USA |
 |
IRadimed Corporation
IRMD
|
34.8 | $ 101.34 | -1.42 % | $ 1.29 B | USA |